APA

von Janta-Lipinski M., Costisella B., Ochs H., Hübscher U., Hafkemeyer P. & Matthes E. (19980624). Newly synthesized L-enantiomers of 3'-fluoro-modified beta-2'-deoxyribonucleoside 5'-triphosphates inhibit hepatitis B DNA polymerases but not the five cellular DNA polymerases alpha, beta, gamma, delta, and epsilon nor HIV-1 reverse transcriptase. : Journal of medicinal chemistry.

Chicago

von Janta-Lipinski M, Costisella B, Ochs H, Hübscher U, Hafkemeyer P and Matthes E. 19980624. Newly synthesized L-enantiomers of 3'-fluoro-modified beta-2'-deoxyribonucleoside 5'-triphosphates inhibit hepatitis B DNA polymerases but not the five cellular DNA polymerases alpha, beta, gamma, delta, and epsilon nor HIV-1 reverse transcriptase. : Journal of medicinal chemistry.

Harvard

von Janta-Lipinski M., Costisella B., Ochs H., Hübscher U., Hafkemeyer P. and Matthes E. (19980624). Newly synthesized L-enantiomers of 3'-fluoro-modified beta-2'-deoxyribonucleoside 5'-triphosphates inhibit hepatitis B DNA polymerases but not the five cellular DNA polymerases alpha, beta, gamma, delta, and epsilon nor HIV-1 reverse transcriptase. : Journal of medicinal chemistry.

MLA

von Janta-Lipinski M, Costisella B, Ochs H, Hübscher U, Hafkemeyer P and Matthes E. Newly synthesized L-enantiomers of 3'-fluoro-modified beta-2'-deoxyribonucleoside 5'-triphosphates inhibit hepatitis B DNA polymerases but not the five cellular DNA polymerases alpha, beta, gamma, delta, and epsilon nor HIV-1 reverse transcriptase. : Journal of medicinal chemistry. 19980624.